Serous cystadenoma of the pancreas: Tumor growth rates and recommendations for treatment

Jennifer F. Tseng, Andrew L. Warshaw, Dushyant V. Sahani, Gregory Y. Lauwers, David W. Rattner, Carlos Fernandez-Del Castillo, Keith D. Lillemoe, Jennifer F. Tseng, Henry A. Pitt, Charles E. Lucas, Hans G. Beger, William W. Turner, John L. Cameron

Research output: Contribution to journalArticle

265 Citations (Scopus)

Abstract

Objective: To define the natural history and optimal management of serous cystadenoma of the pancreas. Summary Background Data: Serous cystadenoma of the pancreas is the most common benign pancreatic neoplasm. Diagnostic criteria, potential for growth or malignancy, and outcomes are not well defined. As a result, management for patients with serous cystadenomas varies widely in current practice. Methods: A total of 106 patients presenting with serous cystadenoma of the pancreas from 1976-2004 were identified. Hospital records were evaluated for patient and tumor characteristics, diagnostic workup, treatment, and outcome. Twenty-four patients with serial radiographic imaging were identified, and tumor growth curves calculated. Results: Mean age at presentation was 61.5 years and 75% of patients were female. The most common symptoms were abdominal pain (25%), fullness/mass (10%), and jaundice (7%); 47% were asymptomatic. Mean tumor diameter was 4.9 ± 3.1 cm, which did not vary by location. Tumors <4 cm were less likely to be symptomatic than were tumors ≥4 cm (22% vs. 72%, P < 0.001). The median growth rate in the patients who had serial radiography was 0.60 cm/y. For tumors <4 cm at presentation (n = 15), the rate was 0.12 cm/y, whereas for tumors ≥4 cm (n = 9), the rate was 1.98 cm/y (P = 0.0002). Overall, 86 patients underwent surgery, with one perioperative death. Conclusions: Large (>4 cm) serous cystadenomas are more likely to be symptomatic. Although the median growth rate for this neoplasm is only 0.6 cm/y, it is significantly greater in large tumors. Whereas expectant management is reasonable in small asymptomatic tumors, we recommend resection for large serous cystadenomas regardless of the presence or absence of symptoms.

Original languageEnglish (US)
Pages (from-to)413-421
Number of pages9
JournalAnnals of Surgery
Volume242
Issue number3
DOIs
StatePublished - Sep 2005

Fingerprint

Serous Cystadenoma
Pancreas
Growth
Neoplasms
Therapeutics
Hospital Records
Jaundice
Natural History
Pancreatic Neoplasms
Abdominal Pain

ASJC Scopus subject areas

  • Surgery

Cite this

Tseng, J. F., Warshaw, A. L., Sahani, D. V., Lauwers, G. Y., Rattner, D. W., Fernandez-Del Castillo, C., ... Cameron, J. L. (2005). Serous cystadenoma of the pancreas: Tumor growth rates and recommendations for treatment. Annals of Surgery, 242(3), 413-421. https://doi.org/10.1097/01.sla.0000179651.21193.2c

Serous cystadenoma of the pancreas : Tumor growth rates and recommendations for treatment. / Tseng, Jennifer F.; Warshaw, Andrew L.; Sahani, Dushyant V.; Lauwers, Gregory Y.; Rattner, David W.; Fernandez-Del Castillo, Carlos; Lillemoe, Keith D.; Tseng, Jennifer F.; Pitt, Henry A.; Lucas, Charles E.; Beger, Hans G.; Turner, William W.; Cameron, John L.

In: Annals of Surgery, Vol. 242, No. 3, 09.2005, p. 413-421.

Research output: Contribution to journalArticle

Tseng, JF, Warshaw, AL, Sahani, DV, Lauwers, GY, Rattner, DW, Fernandez-Del Castillo, C, Lillemoe, KD, Tseng, JF, Pitt, HA, Lucas, CE, Beger, HG, Turner, WW & Cameron, JL 2005, 'Serous cystadenoma of the pancreas: Tumor growth rates and recommendations for treatment', Annals of Surgery, vol. 242, no. 3, pp. 413-421. https://doi.org/10.1097/01.sla.0000179651.21193.2c
Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernandez-Del Castillo C et al. Serous cystadenoma of the pancreas: Tumor growth rates and recommendations for treatment. Annals of Surgery. 2005 Sep;242(3):413-421. https://doi.org/10.1097/01.sla.0000179651.21193.2c
Tseng, Jennifer F. ; Warshaw, Andrew L. ; Sahani, Dushyant V. ; Lauwers, Gregory Y. ; Rattner, David W. ; Fernandez-Del Castillo, Carlos ; Lillemoe, Keith D. ; Tseng, Jennifer F. ; Pitt, Henry A. ; Lucas, Charles E. ; Beger, Hans G. ; Turner, William W. ; Cameron, John L. / Serous cystadenoma of the pancreas : Tumor growth rates and recommendations for treatment. In: Annals of Surgery. 2005 ; Vol. 242, No. 3. pp. 413-421.
@article{72087a78735e4c669637493f6ccc9d65,
title = "Serous cystadenoma of the pancreas: Tumor growth rates and recommendations for treatment",
abstract = "Objective: To define the natural history and optimal management of serous cystadenoma of the pancreas. Summary Background Data: Serous cystadenoma of the pancreas is the most common benign pancreatic neoplasm. Diagnostic criteria, potential for growth or malignancy, and outcomes are not well defined. As a result, management for patients with serous cystadenomas varies widely in current practice. Methods: A total of 106 patients presenting with serous cystadenoma of the pancreas from 1976-2004 were identified. Hospital records were evaluated for patient and tumor characteristics, diagnostic workup, treatment, and outcome. Twenty-four patients with serial radiographic imaging were identified, and tumor growth curves calculated. Results: Mean age at presentation was 61.5 years and 75{\%} of patients were female. The most common symptoms were abdominal pain (25{\%}), fullness/mass (10{\%}), and jaundice (7{\%}); 47{\%} were asymptomatic. Mean tumor diameter was 4.9 ± 3.1 cm, which did not vary by location. Tumors <4 cm were less likely to be symptomatic than were tumors ≥4 cm (22{\%} vs. 72{\%}, P < 0.001). The median growth rate in the patients who had serial radiography was 0.60 cm/y. For tumors <4 cm at presentation (n = 15), the rate was 0.12 cm/y, whereas for tumors ≥4 cm (n = 9), the rate was 1.98 cm/y (P = 0.0002). Overall, 86 patients underwent surgery, with one perioperative death. Conclusions: Large (>4 cm) serous cystadenomas are more likely to be symptomatic. Although the median growth rate for this neoplasm is only 0.6 cm/y, it is significantly greater in large tumors. Whereas expectant management is reasonable in small asymptomatic tumors, we recommend resection for large serous cystadenomas regardless of the presence or absence of symptoms.",
author = "Tseng, {Jennifer F.} and Warshaw, {Andrew L.} and Sahani, {Dushyant V.} and Lauwers, {Gregory Y.} and Rattner, {David W.} and {Fernandez-Del Castillo}, Carlos and Lillemoe, {Keith D.} and Tseng, {Jennifer F.} and Pitt, {Henry A.} and Lucas, {Charles E.} and Beger, {Hans G.} and Turner, {William W.} and Cameron, {John L.}",
year = "2005",
month = "9",
doi = "10.1097/01.sla.0000179651.21193.2c",
language = "English (US)",
volume = "242",
pages = "413--421",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Serous cystadenoma of the pancreas

T2 - Tumor growth rates and recommendations for treatment

AU - Tseng, Jennifer F.

AU - Warshaw, Andrew L.

AU - Sahani, Dushyant V.

AU - Lauwers, Gregory Y.

AU - Rattner, David W.

AU - Fernandez-Del Castillo, Carlos

AU - Lillemoe, Keith D.

AU - Tseng, Jennifer F.

AU - Pitt, Henry A.

AU - Lucas, Charles E.

AU - Beger, Hans G.

AU - Turner, William W.

AU - Cameron, John L.

PY - 2005/9

Y1 - 2005/9

N2 - Objective: To define the natural history and optimal management of serous cystadenoma of the pancreas. Summary Background Data: Serous cystadenoma of the pancreas is the most common benign pancreatic neoplasm. Diagnostic criteria, potential for growth or malignancy, and outcomes are not well defined. As a result, management for patients with serous cystadenomas varies widely in current practice. Methods: A total of 106 patients presenting with serous cystadenoma of the pancreas from 1976-2004 were identified. Hospital records were evaluated for patient and tumor characteristics, diagnostic workup, treatment, and outcome. Twenty-four patients with serial radiographic imaging were identified, and tumor growth curves calculated. Results: Mean age at presentation was 61.5 years and 75% of patients were female. The most common symptoms were abdominal pain (25%), fullness/mass (10%), and jaundice (7%); 47% were asymptomatic. Mean tumor diameter was 4.9 ± 3.1 cm, which did not vary by location. Tumors <4 cm were less likely to be symptomatic than were tumors ≥4 cm (22% vs. 72%, P < 0.001). The median growth rate in the patients who had serial radiography was 0.60 cm/y. For tumors <4 cm at presentation (n = 15), the rate was 0.12 cm/y, whereas for tumors ≥4 cm (n = 9), the rate was 1.98 cm/y (P = 0.0002). Overall, 86 patients underwent surgery, with one perioperative death. Conclusions: Large (>4 cm) serous cystadenomas are more likely to be symptomatic. Although the median growth rate for this neoplasm is only 0.6 cm/y, it is significantly greater in large tumors. Whereas expectant management is reasonable in small asymptomatic tumors, we recommend resection for large serous cystadenomas regardless of the presence or absence of symptoms.

AB - Objective: To define the natural history and optimal management of serous cystadenoma of the pancreas. Summary Background Data: Serous cystadenoma of the pancreas is the most common benign pancreatic neoplasm. Diagnostic criteria, potential for growth or malignancy, and outcomes are not well defined. As a result, management for patients with serous cystadenomas varies widely in current practice. Methods: A total of 106 patients presenting with serous cystadenoma of the pancreas from 1976-2004 were identified. Hospital records were evaluated for patient and tumor characteristics, diagnostic workup, treatment, and outcome. Twenty-four patients with serial radiographic imaging were identified, and tumor growth curves calculated. Results: Mean age at presentation was 61.5 years and 75% of patients were female. The most common symptoms were abdominal pain (25%), fullness/mass (10%), and jaundice (7%); 47% were asymptomatic. Mean tumor diameter was 4.9 ± 3.1 cm, which did not vary by location. Tumors <4 cm were less likely to be symptomatic than were tumors ≥4 cm (22% vs. 72%, P < 0.001). The median growth rate in the patients who had serial radiography was 0.60 cm/y. For tumors <4 cm at presentation (n = 15), the rate was 0.12 cm/y, whereas for tumors ≥4 cm (n = 9), the rate was 1.98 cm/y (P = 0.0002). Overall, 86 patients underwent surgery, with one perioperative death. Conclusions: Large (>4 cm) serous cystadenomas are more likely to be symptomatic. Although the median growth rate for this neoplasm is only 0.6 cm/y, it is significantly greater in large tumors. Whereas expectant management is reasonable in small asymptomatic tumors, we recommend resection for large serous cystadenomas regardless of the presence or absence of symptoms.

UR - http://www.scopus.com/inward/record.url?scp=24944572397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944572397&partnerID=8YFLogxK

U2 - 10.1097/01.sla.0000179651.21193.2c

DO - 10.1097/01.sla.0000179651.21193.2c

M3 - Article

C2 - 16135927

AN - SCOPUS:24944572397

VL - 242

SP - 413

EP - 421

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 3

ER -